166 related articles for article (PubMed ID: 9287939)
21. Evaluation of the efficacy of different antibiotics in inhibiting colonisation of Vibrio cholerae O1 in the rabbit intestine.
Chakrabarti MK; Bhattacharya MK; Sinha AK; Chatterjee DC; Bhattacharya SK
Zentralbl Bakteriol; 1993 Feb; 278(1):69-72. PubMed ID: 8518514
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology and Antibiogram Profile of Vibrio cholerae Isolates between 2004-2013 from Odisha, India.
Pal BB; Nayak SR; Khuntia HK
Jpn J Infect Dis; 2018 Mar; 71(2):99-103. PubMed ID: 29279443
[TBL] [Abstract][Full Text] [Related]
23. The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms.
Vanhoof R; Hubrechts JM; Roebben E; Nyssen HJ; Nulens E; Leger J; De Schepper N
Infection; 1986; 14(6):294-8. PubMed ID: 3546145
[TBL] [Abstract][Full Text] [Related]
24. A localised outbreak of Vibrio cholerae O139 in Kolkata, West Bengal.
Sur D; Sengupta PG; Mondal SK; Dutta P; Gupta DN; Ghosh S; Pandey A; Ramamurthy T; Bhattacharya SK
Indian J Med Res; 2002 Apr; 115():149-52. PubMed ID: 12239837
[TBL] [Abstract][Full Text] [Related]
25. Clinical features, antimicrobial susceptibility and toxin production in Vibrio cholerae O139 infection: comparison with V. cholerae O1 infection.
Dhar U; Bennish ML; Khan WA; Seas C; Huq Khan E; Albert MJ; Abdus Salam M
Trans R Soc Trop Med Hyg; 1996; 90(4):402-5. PubMed ID: 8882188
[TBL] [Abstract][Full Text] [Related]
26. Antibiotic susceptibility patterns of Vibrio cholerae isolates.
Shrestha SD; Malla S; Adhikari BR; Shakya G; Basnyat SR; Sharma S
JNMA J Nepal Med Assoc; 2010; 49(179):232-6. PubMed ID: 22049830
[TBL] [Abstract][Full Text] [Related]
27. A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.
Shrire L; Saunders J; Traynor R; Koornhof HJ
Eur J Clin Microbiol; 1984 Aug; 3(4):328-32. PubMed ID: 6237900
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of Ciprofloxacin for Treatment of Cholera Associated with Diminished Susceptibility to Ciprofloxacin to Vibrio cholerae O1.
Khan WA; Saha D; Ahmed S; Salam MA; Bennish ML
PLoS One; 2015; 10(8):e0134921. PubMed ID: 26271050
[TBL] [Abstract][Full Text] [Related]
29. Survey of in vitro susceptibilities of Vibrio cholerae O1 and O139 to antimicrobial agents.
Yamamoto T; Nair GB; Albert MJ; Parodi CC; Takeda Y
Antimicrob Agents Chemother; 1995 Jan; 39(1):241-4. PubMed ID: 7695314
[TBL] [Abstract][Full Text] [Related]
30. [Experimental resistance of Vibrio cholerae el tor to nalidixic acid and fluoroquinolones].
Ryzhko IV; Tsuraeva RI; Lomov IuM; Shut'ko AG; Mishan'kin BN; Koroleva NS; Samokhodkina ED; Shcherbaniuk AI
Antibiot Khimioter; 2000; 45(9):7-12. PubMed ID: 11057367
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial susceptibility of oral isolates of Enterobacter cloacae and Klebsiella pneumoniae from a southern Chinese population.
Sedgley CM; Samaranayake LP
Oral Microbiol Immunol; 1998 Oct; 13(5):315-21. PubMed ID: 9807124
[TBL] [Abstract][Full Text] [Related]
32. A high proportion of Vibrio cholerae strains isolated from children with diarrhoea in Bangkok, Thailand are multiple antibiotic resistant and belong to heterogenous non-O1, non-O139 O-serotypes.
Dalsgaard A; Forslund A; Bodhidatta L; Serichantalergs O; Pitarangsi C; Pang L; Shimada T; Echeverria P
Epidemiol Infect; 1999 Apr; 122(2):217-26. PubMed ID: 10355785
[TBL] [Abstract][Full Text] [Related]
33. [Resistance of Vibrio cholerae 0:1 to the 0/129 compound and multiresistance to antibiotics].
Bougoudogo F; Fournier JM; Gastellu-Etchegorry M; Guillou M; Dodin A
Bull Soc Pathol Exot; 1992; 85(2):136-41. PubMed ID: 1327350
[TBL] [Abstract][Full Text] [Related]
34. Vibrio cholerae non-O1, non-O139 strains isolated before 1992 from Varanasi, India are multiple drug resistant, contain intSXT, dfr18 and aadA5 genes.
Mohapatra H; Mohapatra SS; Mantri CK; Colwell RR; Singh DV
Environ Microbiol; 2008 Apr; 10(4):866-73. PubMed ID: 18201198
[TBL] [Abstract][Full Text] [Related]
35. [Antibiotic resistance pattern of 24, 526 strains of Vibrio cholerae O1 isolated in Mexico from 1991 to 1993].
Giono-Cerezo S; Zárate A; Gutiérrez L; Valdespino JL
Rev Latinoam Microbiol; 1994; 36(4):257-62. PubMed ID: 7701135
[TBL] [Abstract][Full Text] [Related]
36. [Antibiotic Susceptibility of Vibrio cholerae non O1/non O139 Serogroups Isolated from Environment in the Rostov Region].
Selyanskaya NA; Trishina AV; Verkina LM; Arkhangelskaya IV; Kruglikov VD; Zlenko YM
Antibiot Khimioter; 2014; 59(11-12):16-9. PubMed ID: 26448988
[TBL] [Abstract][Full Text] [Related]
37. Epidemiological cut-off values for non-O1/ non-O139 Vibrio cholerae disc diffusion data generated by standardised methods.
Smith P; Le Devendec L; Jouy E; Larvor E; Lesne J; Kirschner AKT; Rehm C; Leopold M; Pleininger S; Heger F; Jäckel C; Göllner C; Nekat J; Hammerl JA; Baron S
Dis Aquat Organ; 2023 Dec; 156():115-121. PubMed ID: 38095366
[TBL] [Abstract][Full Text] [Related]
38. Fluoroquinolone-resistant Vibrio cholerae isolated during a cholera outbreak in India.
Krishna BV; Patil AB; Chandrasekhar MR
Trans R Soc Trop Med Hyg; 2006 Mar; 100(3):224-6. PubMed ID: 16246383
[TBL] [Abstract][Full Text] [Related]
39. In vitro antimicrobial effect of cefazolin and cefotaxime combined with minocycline against Vibrio cholerae non-O1 non-O139.
Su BA; Tang HJ; Wang YY; Liu YC; Ko WC; Liu CY; Chuang YC;
J Microbiol Immunol Infect; 2005 Dec; 38(6):425-9. PubMed ID: 16341343
[TBL] [Abstract][Full Text] [Related]
40. Transferable plasmid-mediated drug resistance among non-O1 Vibrio cholerae and rough strains of Vibrio cholerae from Tamilnadu, India.
Sundaram S; Murthy KV
J Hyg (Lond); 1984 Feb; 92(1):59-65. PubMed ID: 6607275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
